NOV 13, 2020 4:00 PM PST

Fluorescent multiplexing of 3D spheroid FFPE with Roche automated stainer and reagents: assay optimization, imaging and future implications

Speaker
  • Staff Scientist
    Biography

      Srabani Bhaumik is a Staff Scientist in the Strategic Applications and Innovation Lab at Roche Tissue Diagnostics. Her R&D experiences includes molecular imaging, molecular pathology, small animal imaging, MRI contrast media imaging, reporter gene imaging, regenerative medicine and in-vitro assay development in oncology. Her current work is focused on fluorescent multiplexing (mIF) assay development on Roche automated IHC/ISH instruments, image acquisition and image analysis on multiple platforms. She was the technical lead for the development and launch of the fluorescent RUO 5-Plex assay on Roche Discovery platform. She has successfully developed complex fluorescent multiplex assays on various oncology samples including 3D cell spheroids and cytology. Prior to Roche, she worked at General Electric Global Research, where she focused on the MultiOmyx platform to explore immune oncology biomarker.


    Abstract

    Three-dimensional (3D) cell culture spheroids and aggregates are preferred over monolayer cell culture due to their architectural and functional similarity to solid tumors. To study expression profiles of key tumor biomarkers, physiologically relevant preclinical models of non-small cell lung adenocarcinoma, and colon and colorectal adenocarcinoma cell line‐derived 3D spheroids and aggregates were utilized. We performed multiplex immunofluorescence (mIF) staining, whole slide scanning and image analysis to enable simultaneous detection and quantification of multiple biomarkers on a single formalin-fixed paraffin embedded section.
    We describe the workflow optimized in our lab at Roche Tissue Diagnostics to establish mIF assay for 3D spheroids and aggregates sections. Multiplex staining of 3D sections were performed on Roche DISCOVERY Ultra automated staining instruments with Roche reagent and fluorescent dyes. Biomarker panels were designed to examine the expression of frequently studies key markers of two cancer subtypes. The slides were scanned and multispectral images captured in Vectra 3 (Akoya Biosciences) fitted with filters compatible to the dyes. Quantitative assessment of the expressed biomarkers was performed through image analysis.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 05, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 05, 2020 7:00 AM PST
    DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
    NOV 19, 2020 8:00 AM GMT
    C.E. CREDITS
    NOV 19, 2020 8:00 AM GMT
    Date: November 19, 2020 Time: 12:00am (PDT), 9:00am (CET), 4:00pm (SGT) We present split-FISH, a multiplexed fluorescence in situ hybridization method that leverages a split-probe design to...
    Loading Comments...
    Show Resources